glp 1 agonist stands for GLP-1 Agonists - What is it? TrimRX | GLP-1 vs GIP:

This is because clinical trials have not been long enough to assess pancreatic cancer risk, and the risk may still be present

PMID 41459016

The widespread distribution and function of multiple GLP-1 receptor populations in the central and autonomic nervous system provide the anatomical foundation for the appetite-suppressing effects observed with GLP-1 agonist therapy

Tolerability Issues : The adverse events with the GLP-1-based therapies are primarily gastrointestinal and include nausea, vomiting, constipation, or diarrhea [82], leading to meaningful discontinuation rates that limit real-world effectiveness

ISSN 2836-7677

Oral GLP-1 Formulations and Future Projections Several companies are developing oral GLP-1 formulations, including Novo Nordisk, Pfizer, and smaller firms, positioning them as potential acquisition targets